HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olaf Van Tellingen Selected Research

Olaf Van Tellingen Research Topics

Disease

4Neoplasms (Cancer)
11/2013 - 01/2009
2Neoplasm Metastasis (Metastasis)
11/2013 - 01/2009
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2013
1Aneuploidy (Aneuploid)
09/2013
1Glioblastoma (Glioblastoma Multiforme)
09/2013
1Neutropenia
05/2009
1Colonic Neoplasms (Colon Cancer)
01/2009
1Melanoma (Melanoma, Malignant)
01/2009
1Experimental Melanoma
01/2009

Drug/Important Bio-Agent (IBA)

1Cytidine DeaminaseIBA
11/2013
1LuciferasesIBA
11/2013
1CrizotinibIBA
11/2013
1GemcitabineFDA Link
11/2013
1Antimitotic AgentsIBA
09/2013
11- (4- (6- (2- (isopropylsulfonyl)phenylamino)- 9H- purin- 2- ylamino)- 3- ethoxyphenyl)piperidin- 4- olIBA
09/2013
1Vincristine (Oncovin)FDA LinkGeneric
09/2013
1Paclitaxel (Taxol)FDA LinkGeneric
09/2013
1palomid 529IBA
12/2011
1Mechanistic Target of Rapamycin Complex 1IBA
12/2011
1Mechanistic Target of Rapamycin Complex 2IBA
12/2011
1Vinorelbine (Navelbine)FDA LinkGeneric
05/2009
1tariquidar (XR9576)IBA
05/2009
1RhodaminesIBA
05/2009
1ThrombinFDA Link
01/2009
1Thromboplastin (Tissue Factor)IBA
01/2009
1Proteinase-Activated ReceptorsIBA
01/2009
1P-SelectinIBA
01/2009
1FibrinIBA
01/2009
1SelectinsIBA
01/2009
1Fibrinogen (Factor I)FDA Link
01/2009
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2009
1HirudinsIBA
01/2009
1AnticoagulantsIBA
01/2009
1LigandsIBA
01/2009

Therapy/Procedure

1Lasers (Laser)
11/2013